Stimulating effect of the low dose laser - a new hypothesis
Yew, D.T.; Ling Wong, S.L.; Chan, Y.
Acta Anatomica 112(2): 131-136
1982
ISSN/ISBN: 0001-5180 PMID: 6179384 Document Number: 187981
An increase in the amount of secretory material (interreceptor matrix) surrounding visual cells was observed after laser treatment. At the same time, an increase in labeled uridine uptake by the pigment epithelium was detected. The increased uptake was highest 4 h after laser treatment.
Document emailed within 1 workday
Related Documents
Pritchard, M.A.; Kola, I. 1999: The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in down syndrome Journal of Neural Transmission. Supplementum 57: 293-303Libman, E.S.; Kiĭko, I.I.; Ivanov, S.V. 1982: Stimulating laser therapy of corneal diseases with the radiation from a ruby ophthalmocoagulator Oftalmologicheskii Zhurnal 37(4): 204-207
Kashuba, V.A.; Cherkasov, A.V. 1987: Effect of laser and non-laser radiation on the brain (experimental study) Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 87(4): 544-547
Kim, J.H.; Richards, C.J.; Seibel, M.M. 1994: Proper selection of patients for intermediate-dose pure follicle stimulating hormone Journal of Reproductive Medicine 39(1): 1-5
Wright, E.J.; Poppas, D.P. 1997: Effect of laser wavelength and protein solder concentration on acute tissue repair using laser welding: initial results in a canine ureter model Techniques in Urology 3(3): 176-181
Orias, R. 1968: Effect of hypothalamic extracts and stress on the pituitary melanocyte stimulating hormone content in rats abstract in vitro rana pipiens skin follicle stimulating hormone luteinizing hormone growth hormone oxytocin hormone vasopressin hormone Proceedings Int Union Physiology Science 7(24): 332
Orias, R. 1968: Effect of hypothalamic extracts and stress on the pituitary melanocyte stimulating hormone content in rats abstract in vitro rana pipiens skin follicle stimulating hormone luteinizing hormone growth hormone oxytocin hormone vasopressin hormone Proceedings Int Union Physiology Science 7(24): 332
Gerhartz, H.H.; Visani, G.; Delmer, A.; Zwierzina, H.; Ribeiro, M.; Jacobs, A.; Marcus, R.; Baumelou, M.; Fière, D.; Labar, B. 1989: Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group Bone Marrow Transplantation 4(Suppl 3): 36-37
Marty, M. 1994: The optimal dose of glycosylated recombinant human granulocyte colony stimulating factor for use in clinical practice: a review European Journal of Cancer 30a Suppl 3: S20-S25
Joffe, J.K.; Bell, J.B.; Denham, S.; Adshead, F.; Millar, J.L.; Millar, B.C. 1995: G-CSF is a major component of colony-stimulating activity (CSA) in the plasma of patients with multiple myeloma after treatment with high-dose melphalan (HDM) Experimental Hematology 23(4): 376-382
Camera, A.; Volpicelli, M.; Villa, M.R.; Risitano, A.M.; Rossi, M.; Rotoli, B. 2002: Complete remission induced by high dose erythropoietin and granulocyte colony stimulating factor in acute erythroleukemia (AML-M6 with maturation) Haematologica 87(11): 1225-1227
Osugi, Y.; Keisei, K.H.; Murayama, N.; Inoue, M.; Ishihara, S.; Hara, J.; Yagi, K.; Tawa, A.; Okada, S.; Izumi, Y. 1990: Effects of recombinant human granulocyte colony stimulating factor following high-dose cytosine arabinoside therapy in children with malignancy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(7): 1379-1382
Taguchi, H.; Shishido, T.; Niitsu, N.; Hiraoka, A.; Kageyama, T.; Kanamaru, A.; Ogawa, M. 1998: High-dose biweekly CHOP chemotherapy with granulocyte colony-stimulating factor support for patients with aggressive non-Hodgkin lymphoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(4): 523-529
Palackdharry, C.S.; Krigel, R.L. 1994: Dose-intensive ifosfamide/carboplatin/etoposide plus granulocyte-macrophage colony-stimulating factor for non-small cell lung cancer Seminars in Oncology 21(3 Suppl 4: 6-11
Rosell, R.; Gómez-Codina, J.; Anton, A.; Sánchez, J.J.; Vadell, C. 1994: Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage colony-stimulating factor use when appropriate Seminars in Oncology 21(1 Suppl 1: 48-53
Fujikawa, Y.; Sabokbar, A.; Neale, S.D.; Itonaga, I.; Torisu, T.; Athanasou, N.A. 2001: The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-alpha, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells Bone 28(3): 261-267
Norris, L.A.; Bonnar, J. 1994: Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives Thrombosis and Haemostasis 72(6): 926-930
el-Araud, K.A.; Clark, B.J.; Kaahwa, C.; Anum, P.; Chrystyn, H. 1998: The effect of dose on the characterization of aerodynamic particle-size distributions of beclomethasone dipropionate metered-dose inhalers Journal of Pharmacy and Pharmacology 50(10): 1081-1085
Khedun, S.M.; Maharaj, B.; Naicker, T. 1996: The effect of a low dose versus a conventional dose of hydrochlorothiazide on ventricular fibrillation threshold and electrolyte levels in laboratory rats Brazilian Journal of Medical and Biological Research 29(10): 1373-1378
Colpaert, F.C.; Janssen, P.A. 1982: Factors regulating drug cue sensitivity: the effects of dose ratio and absolute dose level in the case of fentanyl dose-dose discrimination Archives Internationales de Pharmacodynamie et de Therapie 258(2): 283-299